-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114.O2.6 114. Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological: Hydroxyurea Treatment

Symposia: Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, clinical trials, adult, Non-Biological therapies, epidemiology, assays, Clinical Research, Hemoglobinopathies, pediatric, Diseases, Therapies, Adverse Events, young adult , Biological Processes, Technology and Procedures, molecular biology, Study Population, Human, molecular testing
Saturday, December 10, 2022: 2:00 PM-3:30 PM
278-282 (Ernest N. Morial Convention Center)
Moderators:
Russell E. Ware, Children's Hospital Medical Center and Raffaella Colombatti, MD, PhD, University of Padova
Disclosures:
Ware: BMS: Research Funding; Addmedica: Research Funding; Hemex Health: Research Funding; Nova Laboratories: Membership on an entity's Board of Directors or advisory committees; Novartis: Other: DSMB Chair; Editas: Other: DSMB Chair. Colombatti: Novo Nordisk: Consultancy, Membership on an entity's Board of Directors or advisory committees; Bluebird Bio: Research Funding; Novartis: Membership on an entity's Board of Directors or advisory committees; Global Blood Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; AddMedica: Membership on an entity's Board of Directors or advisory committees; Forma Therapeutics: Membership on an entity's Board of Directors or advisory committees; Vertex: Membership on an entity's Board of Directors or advisory committees.
This session will include new research and clinical trial results for hydroxyurea treatment of sickle cell anemia.
2:00 PM

Meghna Dua, MD, MS1*, Winfred C. Wang, MD2, R. Clark Brown, MD, PhD3, Melissa A. McNaull, MD4, Zora R. Rogers, MD5, Martha Barton, PhD6*, Jane S Hankins, MD, MS7,8, Jeffrey Gossett, MS6*, Julie Richardson, PharmD9*, Jerlym S. Porter, PhD, MPH10, Guolian Kang, PhD, MS6 and Jeremie H. Estepp, MD1,2

1Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN
2Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
3Emory University School of Medicine, Atlanta, GA
4University of Mississippi Medical Center, Jackson, MS
5University of Texas Southwestern Medical Center, Dallas, TX
6Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
7Department of Hematology, St. Jude Children's Research Hospital, MEMPHIS, TN
8St. Jude Children's Research Hospital - Department of Global Pediatric Medicine, Memphis
9Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
10Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN

2:15 PM

Emmanuela E. Ambrose, MD1,2, Teresa Latham, MA3*, Primrose Songoro, RN1*, Mwesige Charles, BScHLS4*, Adam Lane, PhD3*, Susan E. Stuber, MA3,5*, Abel Nkono Makubi, PhD, MD, MSc6*, Russell E. Ware3,5,7 and Luke R. Smart, MD3,5,7

1Department of Paediatrics and Child Health, Bugando Medical Centre, Mwanza, Tanzania, United Republic of
2Department of Paediatrics and Child Health, Catholic University of Health & Allied Sciences, Mwanza, Tanzania, United Republic of
3Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Department of Laboratory Science, Bugando Medical Centre, Mwanza, Tanzania, United Republic of
5Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
6Bugando Medical Centre, Mwanza, Tanzania, United Republic of
7Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

2:30 PM

Mariane de Montalembert, MD, PhD1, Frédéric Galactéros, MD, PhD2*, Lena Oevermann, MD3*, Giovanna Cannas, MD4*, Laure Joseph, MD5*, Gylna Loko, MD6*, Narcisse Elenga, MD, PhD7*, Malika Benkerrou, MD8*, Maryse Etienne-Julan, MD9*, Marie-Pierre Castex, MD10*, Regine Grosse, MD11* and Valentine Brousse, MD, PhD12*

1Pediatrics, Hospital Necker, Paris, France
2Unité des Maladies Génétiques du Globule Rouge, CHU Henri Mondor, Créteil, France
3Charité Berlin, Berlin, Be, DEU
4Edouard Herriot Hospital, Lyon, France
5Biotherapy Department, French National Sickle Cell Referral Center, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, DC, France
6Martinique University Hospital, Le Lamentin, Martinique
7CH AndréE Rosemon, Cayenne, FRA
8Centre de la Drépanocytose, Service d’Immuno-hématologie, Hôpital Universitaire Robert Debré, APHP, Paris, France
9CHU De Pointe-à-Pitre, Pointe-à-Pitre, Guadeloupe
10Pediatrics, Hematology and Oncology department, Children Hospital, Toulouse, FRA
11Clinic of Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
12Robert Debré Hospital, Paris, France

2:45 PM

Rosa M. Nieves, MD1*, Teresa Latham, MA2*, Nicolle Marte, MD1*, Luisanna Sanchez, MD1*, Melissa E. Berges, MD1*, Gabriela S. Urcuyo, MD1*, Carla Florencio, MD1*, Carla Gonzalez, MD1*, Paola Del Villar, MD1*, Sheena Chen, MD1*, Paula Reyes, MD1*, Daniel Ramirez, MD1*, Euladys Matos, MD1*, Manuel Marinez, MD3*, Susan E. Stuber, MA2,4*, William Schultz, MHS, PA2*, Adam Lane, PhD2,5*, Rafael Mena, MD6* and Russell E. Ware2,4

1Robert Reid Cabral Hospital, Santo Domingo, Dominican Republic
2Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Centro de Obstetricia y Ginecologia, Santo Domingo, Dominican Republic
4Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5University of Cincinnati - College of Medicine, Cincinnati, OH
6Centro de Obstetricia y Ginecología, Santo Domingo, Dominican Republic

3:00 PM

Tamara Diesch, MD1*, Catherine Poirot, MD, PhD2*, Carlos Sanchez3*, Andrew Atkinson3*, Corinne Pondarré4*, Nathalie Dhedin, MD5*, Benedicte Neven, MD6*, France Pirenne, MD, PhD7, Gilles Leanour8*, Isabelle Broncheriou8*, Françoise Bernaudin, MD9 and Jean-Hugues Dalle, MD, PhD10*

1Department of Pediatric Hematology/Oncology, University Children's Hospital of Basel, UKBB, Basel, Switzerland
2Department of Hematology, AYA Unit, Saint Louis Hospital, Paris, France, Paris, France
3Pediatric Research Center, University Children`s Hospital Basel, University of Basel, Basel, Switzerland
4French Referral Center for Sickle Cell Disease, Centre Hospitalier Intercommunal Créteil, Université Paris XII, Créteil, France
5St-Louis Hospital, APHP, Adolescents and Young Adults Hematology Department, Paris, France
6Hopital Necker Enfants Malades, Paris, FRA
7French Blood Agency Ile de France, INSERM U955, Laboratory of Excellence GR-Ex, IMRB, Paris Est-Creteil University, CRETEIL, France
8Groupe Hospitalier Pitié- Salpetrière, Department of pathology, Paris, France
9Referral Center for Sickle Cell Disease, Pediatrics, Hopital Intercommunal de Creteil, CRETEIL, France
10Pediatric Hematology and Immunology Department, Hôpital Robert Debré and Université de Paris, Paris, France

3:15 PM

Katherine C Wood, PhD1, Fabliha A Chowdhury2*, Seyed M Nouraie, MD, PhD3,4, Mark T. Gladwin, MD5 and Adam C Straub, PhD1,6*

1Heart, Lung, Blood and Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
2Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
3Department of Medicine, Pulmonary, Allergy, Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA
4Department of Medicine, University of Pittsburgh, Pittsburgh, PA
5Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
6Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA

*signifies non-member of ASH